🎉 Free to use until Sep 16, 2026 — try it out for our launch!
STOCKIQAISTOCKIQAI
עברית
S&P 5007,709.96▼ 0.18%
Dow Jones53,885.1▼ 0.85%
Nasdaq26,348.35▼ 0.06%
Russell 20003,001.55▼ 0.58%
Fear Index (VIX)15.31▲ 1.06%
TA-125₪4,050.45▲ 0.45%
S&P 5007,709.96▼ 0.18%
Dow Jones53,885.1▼ 0.85%
Nasdaq26,348.35▼ 0.06%
Russell 20003,001.55▼ 0.58%
Fear Index (VIX)15.31▲ 1.06%
TA-125₪4,050.45▲ 0.45%

MMED

MiniMed Group Inc. Common Stock

Health Care · ·

$18.42

▼ $0.14 (-0.8%)

Market Cap

$5.17B

Day Range

$18.32 - $18.95

52-Week Range

$10.65 - $20.48

Beta

—

Next Earnings

—

MMED is a stock from the Healthcare sector — Pharmaceuticals, biotech, medical devices, and health insurance — less sensitive to economic cycles, but exposed to regulation and FDA approvals.

🏢 Similar Stocks in the Same Sector

AAPG

Ascentage Pharma Group International - American Depository

AARD

Aardvark Therapeutics, Inc.

ABCL

AbCellera Biologics Inc. - Common

+0.4% (1Y)

Investor Score
51/ 100C-
🟡 Moderate

This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer

📈82A-Technical
💰35FFundamental
🚀37FGrowth
💎38FValuation
📰56CNews
🏦42DQuality
⚠️48D+Risk

Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%

🔍 Cross-Check

Overall Score

🟡 Mixed

Technical Trend

🟢 Bullish

✅ Why is the score relatively high?

  • 🟢 Current ratio: 1.92
  • 🟢 Price is above the 50-day average
  • 🟢 MACD histogram is positive — rising momentum
  • 🟢 RSI 66.9 — healthy positive momentum
  • 🟢 +54.2% over the last 3 months relative to the index

⚠️ What's concerning?

  • 🔴 Estimated fair value: -$31.97 vs. price $18.42 (-273.5%)
  • 🔴 Operating margin: -6.1% (negative)
  • 🔴 Net margin: -10.7% (negative)
  • 🔴 Operating margin is eroding over time
  • 🔴 ATR: 4.6% of price

🚦 Quality & Risk Checks

🔴 Operating margin stability🔴 Daily volatility (ATR)🟢 Liquidity risk

📰 News Trend

Based on real financial news (Finnhub)
🟡 Mixed

Everyone's writing about MiniMed Group Inc. Common Stock. News trend score: 56. Reason: 1 of the last 10 articles are positive, versus 0 negative.

🟡 This Stock Is Knocking on the Door of the Dividend Kings -- and Wall Street Thinks It Has Room to Run — Motley Fool🟢 UBS Initiates MiniMed Group at Buy With $25 Price Target — MT Newswires🟡 MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access — Zacks

News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer

📈 Technical Analysis

Based on the last 105 trading days, calculated from real price data. Click an indicator for details and a chart.

🟢 Most indicators support an uptrend (9 bullish · 2 bearish · 0 neutral)

Conclusions

  • 🟢Price vs. SMA 50 — Price is above the 50-day average
  • 🟢MACD — MACD histogram is positive — rising momentum
  • 🟢RSI — RSI 66.9 — healthy positive momentum
  • 🔴Stochastic — %K 80.7 — overbought
  • 🟢ADX (trend strength) — ADX 35.0 — strong trend
  • 🔴Volume trend — Volume is falling despite the price advance — possible weakening
  • 🟢Relative strength vs. S&P 500 — +54.2% over the last 3 months relative to the index
  • 🟢Bollinger Bands — Price is in the upper third of the Bollinger Bands (81%B) — strong momentum (risk of a pullback)
  • 🟢ROC (rate of change) — ROC 12 days: 9.7%
  • 🟢Parabolic SAR — Price is above the SAR point — uptrend
  • 🟢CMF (money flow) — CMF 20 days: 0.07

Wyckoff Method Analysis

A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.

Markup

The stock is in a clear uptrend with no defined trading range in the period examined.

High confidence

Evidence Behind This Read

  • 🟢Rising price trend — A 66.0% change over the last 50 days, with no defined trading range.

The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.

🎯 Trade Planning (M.A.E.E Framework)

Based on a mechanical trading method: market structure → value zone → ATR-based exit point. Not investment advice — a calculation tool only.

1️⃣ Market Structure

Not enough history to determine market structure (200-day average required).

2️⃣ Value Zone

🟡 Price far from value zone

The price is currently far from the 50-day average — the method recommends waiting for a "pullback" before entering, rather than chasing prices.

Not enough data (ATR / support / resistance) to calculate a suggested exit point.

💰 Financial Health

Profitability

Gross Margin

54.2%

Operating Margin

-6.1%

Net Margin

-10.7%

EBITDA Margin

-1.1%

Efficiency

ROE

-9.2%

ROA

-7.2%

ROIC

—

EPS

-$1.30

Balance Sheet

Cash

$298.00M

Total Debt

—

Current Ratio

1.92

Debt/Equity

—

Conclusions

  • 🟢Gross margin — Gross margin: 54.2% — strong
  • 🔴Operating margin — Operating margin: -6.1% (negative)
  • 🔴Net margin — Net margin: -10.7% (negative)
  • 🔴Return on equity (ROE) — Return on equity (ROE): -9.2% (negative)
  • 🔴Return on assets (ROA) — Return on assets (ROA): -7.2% — weak
  • 🟢Current ratio (liquidity) — Current ratio: 1.92

🚀 Growth

Revenue

Earnings per Share (EPS)

Net Income

Free Cash Flow (FCF)

Conclusions

  • 🟢Revenue growth (last year) — Revenue growth (last year): 14.3%
  • 🔴Earnings per share (EPS) growth — Earnings per share (EPS) growth: -54.8%
  • 🔴Free cash flow growth — Free cash flow growth: -692.5%
  • 🔴Net income growth — Net income growth: -56.3%

💎 Fair Value (Valuation)

Current Price

$18.42

Estimated Fair Value (DCF)

-$31.97

Gap

-273.5%

🔴 Appears expensive relative to estimated value

Show all model (DCF) assumptions →

Year 1 Growth Rate

12.1%

Discount Rate (WACC)

9.0%

Terminal Growth Rate

2.5%

Projection Years

5

YearGrowth RateProjected FCFPresent Value
112.1%$-470.86M$-431.98M
29.7%$-516.56M$-434.78M
37.3%$-554.29M$-428.02M
44.9%$-581.47M$-411.93M
52.5%$-596.00M$-387.36M

Base FCF (last actual year)

$-420.00M

Terminal Value

$-9.40B

Present Value of Terminal Value

$-6.11B

Enterprise Value

$-8.20B

Net Debt

$0

Equity Value

$-8.20B

*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.

Book Value per Share

$14.07

Tangible Book Value per Share (Tangible NAV)

$4.86

Conclusions

  • 🔴DCF Fair Value — Estimated fair value: -$31.97 vs. price $18.42 (-273.5%)
  • 🟡Tangible Net Asset Value (NAV) — NAV per share: $4.86
  • 🟡P/E — P/E: -14.3

🕴️ Insider Trading

Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 0 sales out of the last 25 filings.

NameTransaction TypeDateSharesChangePrice
Dallara QueTax Withholding in Shares31.7.202631,350-31,350$18.15
Dianaty AliTax Withholding in Shares31.7.20268,012-8,012$18.15
Wills Courtney NelsonTax Withholding in Shares31.7.20261,762-1,762$18.15
Chandrasena GillianTax Withholding in Shares28.7.20262,099-2,099$17.67
Spooner ChadTax Withholding in Shares28.7.202623,301-23,301$17.67
Dallara QueGrant/Award from Employer1.7.2026297,618+297,618—
Dianaty AliGrant/Award from Employer1.7.202636,762+36,762—
Dianaty AliGrant/Award from Employer1.7.202694,550+94,550—
Spooner ChadGrant/Award from Employer1.7.202622,057+22,057—
Spooner ChadGrant/Award from Employer1.7.202694,550+94,550—
Chandrasena GillianGrant/Award from Employer1.7.202614,705+14,705—
Chandrasena GillianGrant/Award from Employer1.7.202629,483+29,483—
Gyurci JohnGrant/Award from Employer1.7.202624,244+24,244—
Wills Courtney NelsonGrant/Award from Employer1.7.202622,057+22,057—
Wills Courtney NelsonGrant/Award from Employer1.7.202660,730+60,730—
Dallara QueTax Withholding in Shares25.3.20264,809-4,809$16.31
Wills Courtney NelsonGrant/Award from Employer11.3.20265,743+5,743—
Wills Courtney NelsonGrant/Award from Employer11.3.202613,646+13,646—
Wills Courtney NelsonGrant/Award from Employer11.3.20265,151+5,151—
Wills Courtney NelsonGrant/Award from Employer11.3.202611,486+11,486—
Wills Courtney NelsonGrant/Award from Employer11.3.2026955+955—
Wills Courtney NelsonGrant/Award from Employer11.3.202618,082+18,082—
Chandrasena GillianGrant/Award from Employer11.3.202611,486+11,486—
Chandrasena GillianGrant/Award from Employer11.3.202611,486+11,486—
Chandrasena GillianGrant/Award from Employer11.3.202658,825+58,825—

📉 Short Interest

Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.

Monthly Trend — Open Short Interest

↓-3.4%

6,345,677 shares short as of 2026-07-15 · vs. 6,570,728 on 2026-06-30

Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.

Weekly Trend — Daily Short-Sale Activity

↑+51.6%

60.7% of trading volume this week was short selling, vs. 40.0% the prior week

Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.

📰 News & Sentiment

Sentiment based on basic keywords (not AI) — 1 positive, 9 neutral, 0 negative out of the last 10 articles.